NYSE:CNMDMedical Equipment
Assessing CONMED (CNMD) Valuation As Revenue Growth Trails Sector And A 1.3% Decline Is Forecast
Event driven rethink of CONMED (CNMD)
Recent commentary that CONMED (CNMD) could see a 1.3% revenue decline over the next year, after sales growth already lagged the broader healthcare sector, has sharpened investor focus on the company's demand outlook.
See our latest analysis for CONMED.
At a share price of US$37.28, CONMED has seen pressure build over time, with a 30 day share price return of an 11.93% decline and a 1 year total shareholder return of a 36.16% loss. This points to fading...